Related references
Note: Only part of the references are listed.Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition
Shirin Bajaj et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor
Lena A. von Schuckmann et al.
JAMA DERMATOLOGY (2019)
NK Cell Metabolism and Tumor Microenvironment
Inigo Terren et al.
FRONTIERS IN IMMUNOLOGY (2019)
Multiple Cytokine Profiling: A New Model to Predict Response to Tumor Necrosis Factor Antagonists in Ulcerative Colitis Patients
Igor Vladimirovich Obraztsov et al.
INFLAMMATORY BOWEL DISEASES (2019)
Melanoma: Where we are and where we go
Ali Mohammadpour et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment
Makenzie L. Hawkins et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Xianjie Jiang et al.
MOLECULAR CANCER (2019)
A role for paracrine interleukin-6 signaling in the tumor microenvironment in prostate tumor growth
Shu-Han Yu et al.
PROSTATE (2019)
Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors
Serigne N. Lo et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
The Role of Dermcidin in the Diagnosis and Staging of Hepatocellular Carcinoma
Feng Qiu et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2018)
Fibroblasts potentiate melanoma cells in vitro invasiveness induced by UV-irradiated keratinocytes
Njainday Pulo Jobe et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2018)
Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma
Evan Stiegel et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Conditional recurrence-free survival in patients with primary stage I-II cutaneous malignant melanoma - a population-based study
Johan Lyth
MELANOMA RESEARCH (2018)
The new era of adjuvant therapies for melanoma
Alexander M. M. Eggermont et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing-Remitting-Multiple Sclerosis Patients
Chiara D'Angelo et al.
FRONTIERS IN IMMUNOLOGY (2018)
Concordance and Reproducibility of Melanoma Staging According to the 7th vs 8th Edition of the AJCC Cancer Staging Manual
Joann G. Elmore et al.
JAMA NETWORK OPEN (2018)
Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer
Yun-Feng Ma et al.
ONCOTARGET (2017)
Beyond differences in means: robust graphical methods to compare two groups in neuroscience
Guillaume A. Rousselet et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2017)
Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway
Ting-ting Wang et al.
GUT (2017)
Tumor-related interleukins: old validated targets for new anti-cancer drug development
Sarra Setrerrahmane et al.
MOLECULAR CANCER (2017)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Role of tumor microenvironment in tumorigenesis
Maonan Wang et al.
JOURNAL OF CANCER (2017)
Inflammatory Cytokine Pattern Is Sex-Dependent in Mouse Cutaneous Melanoma Experimental Model
Mihaela Surcel et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
The Human Antimicrobial Peptides Dermcidin and LL-37 Show Novel Distinct Pathways in Membrane Interactions
Kornelius Zeth et al.
FRONTIERS IN CHEMISTRY (2017)
Defining an Optimal Cut-Point Value in ROC Analysis: An Alternative Approach
Ilker Unal
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2017)
Profiling of cytokines, chemokines and other soluble proteins as a potential biomarker in colorectal cancer and polyps
Nor Adzimah Johdi et al.
CYTOKINE (2017)
Prospective Validation of Molecular Prognostic Markers in Cutaneous Melanoma: A Correlative Analysis of E1690
Mohammed Kashani-Sabet et al.
CLINICAL CANCER RESEARCH (2017)
IL-4 blockade alters the tumor microenvironment and augments the response to cancer immunotherapy in a mouse model
Shuku-ei Ito et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
Jeffrey E. Gershenwald et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Adipose Progenitor Cell Secretion of GM-CSF and MMP9 Promotes a Stromal and Immunological Microenvironment That Supports Breast Cancer Progression
Francesca Reggiani et al.
CANCER RESEARCH (2017)
Evaluation of a biomarker based blood test for monitoring surgical resection of oral squamous cell carcinomas
Martin Grimm et al.
CLINICAL ORAL INVESTIGATIONS (2016)
Prognostic and predictive biomarkers in melanoma: an update
Mona Foth et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal
Kelly L. Singel et al.
IMMUNOLOGICAL REVIEWS (2016)
Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma
Idoia Ortega-Martinez et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031
David C. Whiteman et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature
Fernanda Costa Svedman et al.
CLINICAL EPIDEMIOLOGY (2016)
Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types
In-Sun Hong
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Revisiting determinants of prognosis in cutaneous melanoma
Sarah A. Weiss et al.
CANCER (2015)
High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib
Tzu-Hsuan Lin et al.
CLINICAL CANCER RESEARCH (2015)
GM-CSF: An immune modulatory cytokine that can suppress autoimmunity
Palash Bhattacharya et al.
CYTOKINE (2015)
Blood-sampling collection prior to surgery may have a significant influence upon biomarker concentrations measured
Nicolas Kahn et al.
CLINICAL PROTEOMICS (2015)
Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis
Shuai Zhao et al.
PLOS ONE (2015)
Molecular markers in melanoma
M. Kashani-Sabet
BRITISH JOURNAL OF DERMATOLOGY (2014)
Follow-up in melanoma patients
Piotr Rutkowski et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2014)
Structure-Activity Analysis of the Dermcidin-derived Peptide DCD-1L, an Anionic Antimicrobial Peptide Present in Human Sweat
Maren Paulmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Circulating Serologic and Molecular Biomarkers in Malignant Melanoma
Shanique R. Palmer et al.
MAYO CLINIC PROCEEDINGS (2011)
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
Vasilena Gocheva et al.
GENES & DEVELOPMENT (2010)
Evidence of Systemic Th2-Driven Chronic Inflammation in Patients with Metastatic Melanoma
Wendy K. Nevala et al.
CLINICAL CANCER RESEARCH (2009)
A practical solution to the pervasive problems of p values
Eric-Jan Wagenmakers
PSYCHONOMIC BULLETIN & REVIEW (2007)
Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma
MD Boyano et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
